Form 8-K - Current report:
SEC Accession No. 0001641172-25-008680
Filing Date
2025-05-05
Accepted
2025-05-05 16:01:32
Documents
13
Period of Report
2025-05-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35919
  Complete submission text file 0001641172-25-008680.txt   213044

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE fblg-20250502.xsd EX-101.SCH 3033
3 XBRL LABEL FILE fblg-20250502_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE fblg-20250502_pre.xml EX-101.PRE 24177
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3810
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 25912758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)